Analysis of Mechanism of Artesunate in Treatment of Liver Cancer Based on Metabolomics

Hui-guo WANG; Si-yao WANG; Xin-long HAN; Yu-tong LI; Li-xia YUAN; Xiao-mei TAN; Qing-fa TANG; Xue-feng XING; Fei-long CHEN; Ya-lei YIN; Ling TANG

doi:10.13422/j.cnki.syfjx.20191548

您当前的位置：

首页 >

文章列表页 >

Analysis of Mechanism of Artesunate in Treatment of Liver Cancer Based on Metabolomics

Drug Metabolism | 更新时间：2021-02-09

- Analysis of Mechanism of Artesunate in Treatment of Liver Cancer Based on Metabolomics
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 22, Pages: 78-85(2019)
- 作者机构：
  
  1.大连大学　生命科学与技术学院，辽宁　大连　 116622；
  2.中国科学院　大连化学物理研究所中国科学院分离分析化学重点实验室，转化医学科学研究中心，辽宁　大连　 116023；
  3.南方医科大学　中医药学院，广东省中药制剂重点实验室，广东省中药制剂技术工程实验室，广州　 510515
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20191548
  CLC： R22; R945; R28; Q2; R969.1; O657
- Published：20 November 2019，
  
  Published Online：09 April 2019，
  
  Received：25 December 2018，
- 稿件说明：
扫描看全文
Hui-guo WANG, Si-yao WANG, Xin-long HAN, et al. Analysis of Mechanism of Artesunate in Treatment of Liver Cancer Based on Metabolomics. [J]. Chinese Journal of Experimental Traditional Medical Formulae 25(22):78-85(2019)
DOI：

Hui-guo WANG, Si-yao WANG, Xin-long HAN, et al. Analysis of Mechanism of Artesunate in Treatment of Liver Cancer Based on Metabolomics. [J]. Chinese Journal of Experimental Traditional Medical Formulae 25(22):78-85(2019) DOI： 10.13422/j.cnki.syfjx.20191548.

摘要

目的：

采用GC-MS联用技术探索青蒿琥酯治疗肝癌的作用机制，为该药物在肝癌治疗中的临床应用提供实验依据。

方法：

应用发光法细胞活力检测试剂盒(CellTiter-Glo® Luminescent Cell Viability Assay)检测不同浓度青蒿琥酯(0，12.5，25，50，100 μmol·L

－1

)作用于人肝癌Huh7，SMMC-7721细胞24，48，72 h的活性。采用GC-MS联用技术分析青蒿琥酯作用于2种肝癌细胞(Huh7，SMMC-7721)24 h后代谢物的变化，利用Postrun Analysis 4.41工作站对数据进行预处理，采用偏最小二乘法-判别分析(PLS-DA)对两组差异代谢物进行分析，通过MetaboAnalyst 3.0软件对差异代谢物进行代谢通路分析。

结果：

与正常组相比，青蒿琥酯作用于2种肝癌细胞后，细胞内相同代谢物共有39种发生了显著变化，主要涉及到氨基酰-转运RNA(tRNA)生物合成，丙氨酸、天冬氨酸和谷氨酸代谢，甘氨酸、丝氨酸和苏氨酸代谢，精氨酸和脯氨酸代谢，谷胱甘肽代谢5条代谢通路。

结论：

青蒿琥酯(12.5～100 μmol·L

－1

)均能够抑制肝癌细胞(Huh7，SMMC-7721)的生长，主要涉及到5条代谢通路，这可能是青蒿琥酯抗肝癌的作用途径。

Abstract

Objective:

To study on the antitumor mechanism of artesunate in the treatment of liver cancer based on gas chromatography-mass spectrometry (GC-MS).

Method:

CellTiter-Glo® Luminescent Cell Viability Assay was used to detect activity of artesunate with different concentrations (0

12.5

100 μmol·L

-1

) on human liver cancer Huh7

SMMC-7721 cells for 24

72 h. GC-MS was employed to analyze the changes of metabolites of artesunate in two kinds of hepatoma cells (Huh7

SMMC-7721) for 24 h. The data was preprocessed by Postrun Analysis 4.41 workstation. Partial least squares-discriminant analysis (PLS-DA) was used to analyze two sets of differential metabolites and to analyze metabolic pathways of differential metabolites based on MetaboAnalyst 3.0 software.

Result:

Compared with the normal group

after two kinds of liver cancer cells was treated by artesunate

a total of 39 identical metabolites in the cells have undergone significant changes

which were mainly related to five metabolic pathways

including biosynthesis of aminoacyl-transfer RNA (tRNA)

metabolism of alanine

aspartic acid and glutamic acid

metabolism of glycine

serine and threonine

metabolism of arginine and proline

metabolism of glutathione.

Conclusion:

Artesunate (12.5-100 μmol·L

-1

) can inhibit the growth of liver cancer cells (Huh7

SMMC-7721)

it mainly involves five metabolic pathways

which may be the pathway of artesunate against liver cancer.

关键词

青蒿琥酯代谢组学肝癌细胞Huh7SMMC-7721氨基酸代谢能量代谢

Keywords

artesunatemetabolomicsliver cancerHuh7SMMC-7721amino acid metabolismenergy metabolism

references

Wisniewski J R, Vildhede A, Norén A, et al. In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes [J].J Proteomics, 2016, 136: 234-247.

肖潺潺，陈茂剑，梅凡彪，等．辣椒碱对肝癌SMMC-7721细胞迁移和侵袭的影响及机制[J]．中国实验方剂学杂志，2018，24(18)：124-129．

Nzila A, Al-Zahrani I. Drugs for the treatment of malaria in the Kingdom of Saudi Arabia [J].Saudi Med J, 2013, 34(6): 569-578.

Karunajeewa H A, Kemiki A, Alpers M P, et al. Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea [J].Pediatr Infect Dis J, 2003, 22(3): 251-256.

Ilamathi M, Prabu P C, Ayyappa K A, et al. Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling [J].Biomed Pharmacother, 2016, 82: 72-79.

QIAN P, ZHANG Y W, ZHOU Z H, et al. Artesunate enhances gammadelta T-cell-mediated antitumor activity through augmenting gammadelta T-cell function and reversing immune escape of HepG2 cells [J].Immunopharmacol Immunotoxicol, 2018, 40(2): 107-116.

JING W, DONG H, MIN M, et al. Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma [J].J Cell Biochem, 2019, 120(4): 6026-6034.

王高玉，刘红宁，戈淑超，等．铁皮石斛水提物对胃癌前病变作用的尿液代谢组学分析[J]．中国实验方剂学杂志，2018，24(21)：77-85．

Dunn W B, Broadhurst D I, Atherton H J, et al. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy [J].Chem Soc Rev, 2011, 40(1): 387-426.

刘欢，高洁，尹晶晶，等．不同防腐措施收集大鼠尿液对其内源性代谢物的影响[J]．中国实验方剂学杂志，2019，25(6)：120-124．

Pasikanti K K, Ho P C, CHAN E C. Gas chromatography/mass spectrometry in metabolic profiling of biological fluids [J].J Chromatogr B Analyt Technol Biomed Life Sci, 2008, 871(2): 202-211.

CHAN E C, Pasikanti K K, Nicholson J K. Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry [J].Nat Protoc, 2011, 6(10): 1483-1499.

Lopes A S, Cruz E C, Sussulini A, et al. Metabolomic strategies involving mass spectrometry combined with liquid and gas chromatography [J].Adv Exp Med Biol, 2017, 965: 77-98.

Park H, Kim Y, Sul J W, et al. Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant prostate cancer [J].Prostate, 2015, 75(15): 1747-1759.

王华，胡佳慧，刘翠钗，等．运用细胞代谢组学策略探究薯蓣皂苷元的抗肿瘤作用机制[J]．中国实验方剂学杂志，2018，24(20)：95-101．

ZHOU Y, SONG R, MA C, et al. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method [J].Oncotarget, 2017, 8(13): 20719-20728.

LI Z F, WANG J, HUANG C, et al. Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis [J].Rapid Commun Mass Spectrom, 2010, 24(18): 2765-2775.

WANG Y, YAN L, LIU J, et al. The HNF1α-regulated lncRNA HNF1α-AS1 is involved in the regulation of cytochrome P450 expression in human liver tissues and Huh7 cells [J].J Pharmacol Exp Ther, 2019, 368(3): 353-362.

CHEN W, WU J, SHI H, et al. Hepatic stellate cell coculture enables sorafenib resistance in Huh7 cells through HGF/c-Met/Akt and Jak2/Stat3 pathways [J].Biomed Res Int, 2014, doi: 10.115/2014/764981http://doi.org/10.115/2014/764981.

Kwon S, Jeon J S, Ahn C, et al. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression [J].Biochem Biophys Res Commun, 2016, 479(1): 74-79.

Halama A, Möller G, Adamski J. Metabolic signatures in apoptotic human cancer cell lines [J].OMICS, 2011, 15(5): 325-335.

Nevedomskaya E, Ramautar R, Derks R, et al. CE-MS for metabolic profiling of volume-limited urine samples: application to accelerated aging TTD mice [J].J Proteome Res, 2010, 9(9): 4869-4874.

杨婧，贾彦，王蔚，等．膈下逐瘀汤对大鼠纤维化肝脏组织谷胱甘肽抗氧化系统的影响[J]．中国实验方剂学杂志，2017，23(17)：121-126．

Spitzer S, Volbracht K, Lundgaard I, et al. Glutamate signalling: a multifaceted modulator of oligodendrocyte lineage cells in health and disease [J].Neuropharmacology, 2016, 110(Pt B): 574-585.

Jain M, Nilsson R, Sharma S, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation [J].Science, 2012, 336(6084): 1040-1044.

Sreekumar A, Poisson L M, Rajendiran T M, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression [J].Nature, 2009, 457(7231): 910-914.

ZHANG W C, Shyh-Chang N, YANG H, et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis [J].Cell, 2012, 148(1/2): 259-272.

Possemato R, Marks K M, Shaul Y D, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer [J].Nature, 2011, 476(7360): 346-350.

WANG J, Alexander P, WU L, et al. Dependence of mouse embryonic stem cells on threonine catabolism [J].Science, 2009, 325(5939): 435-439.

CHEN C Y, Hsu Y L, CHEN Y Y, et al. Isokotomolide A, a new butanolide extracted from the leaves of Cinnamomum kotoense, arrests cell cycle progression and induces apoptosis through the induction of p53/p21 and the initiation of mitochondrial system in human non-small cell lung cancer A549 cells [J].Eur J Pharmacol, 2007, 574(2/3): 94-102.

Feun L, YOU M, WU C J, et al. Arginine deprivation as a targeted therapy for cancer [J].Curr Pharm Des, 2008, 14(11): 1049-1057.

Phang J M, Pandhare J, LIU Y. The metabolism of proline as microenvironmental stress substrate [J].J Nutr, 2008, 138(10): 2008S-2015S.

Watford M. Glutamine metabolism and function in relation to proline synthesis and the safety of glutamine and proline supplementation [J].J Nutr, 2008, 138(10): 2003S-2007S.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Exploring Central Regulatory Effect of Chaishao Liujuntang on Chronic Atrophic Gastritis Rats with Liver Depression and Spleen Deficiency Syndrome Based on Metabolomics

Mechanism Analysis of Lung Injury Induced by Water Elution Section of Siegesbeckiae Herba on Rats by ¹H-NMR Metabolomics

Clinical Efficacy and Serum Metabonomics of Duhuo Xuduan Tang in Treating Lumbar Disc Herniation Due to Liver and Kidney Yin Deficiency

Investigation of Mechanism of Qingqiao and Laoqiao on Acute Lung Injury Rats Based on Serum Metabolomics

Related Author

HONG Yinjie

TU Wenling

ZHU Jingru

LUO Wenqian

HUANG Kaiyue

GAN Huijuan

Jie LI

Qing FAN

Related Institution

School of Traditional Chinese Medicine（TCM），Fujian University of TCM

School of Basic Medicine，Zhejiang Chinese Medical University

Zhangzhou Traditional Chinese Medical Hospital

Shanxi University of Chinese Medicine

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰